ZS · DEEP VALUE BRIEFING

Zscaler, Inc. (ZS)

published Sep 18, 2026 · price now $196.62 · market cap $31.5B

WATCH · low confidence — the research’s call on buying at the price it saw, not advice to you.

Information only, not investment advice. Written by AI research agents from SEC filings and market data, and it can be wrong. Check the model below before relying on any of it.

Executive Briefing

Verdict: Retain WATCH at $196. Zscaler may be an excellent asset-light cybersecurity compounder: revenue is growing 25.4%, gross margin is 76.8%, demand is recurring, and zero-trust adoption has a long runway. Negative ROE and ROA alone do not establish business impairment.

The decisive risk is overpayment for unverified owner economics. At a roughly $32 billion valuation, the implied owner-earnings yield ranges from only 1.9% to 3.1% using the debate’s $600 million–$1 billion estimates. The favorable valuation case therefore depends on operating leverage, controlled dilution, and sustained growth all arriving together.

For a Buffett-style investor, this is WATCH/no core purchase, not AVOID. A growth-tolerant portfolio may use a tightly capped 0.5%–1% tracking position, but bullish options activity is not a substitute for a margin of safety.


Risk Judgment

1. Business quality is promising, not yet fully proven

The fundamentals analyst’s AVOID conclusion places too much weight on:

  • ROE of negative 2.4%
  • ROA of negative 0.8%
  • unavailable ROIC

These metrics deserve attention but are incomplete for an asset-light software company whose technology, customer relationships, and installed workflows are largely absent from book capital. Zscaler’s more informative current strengths are:

  • 25.4% revenue growth
  • 76.8% gross margin
  • Recurring subscription economics
  • Exposure to cloud migration, AI adoption, distributed work, and rising cyber threats
  • Operational switching costs created by access policies, application integrations, and compliance workflows

This is not evidence of a declining or distressed business. No information supplied establishes the framework’s hard distress condition of deteriorating operations combined with interest coverage below 1x or an Altman-Z distress reading.

However, gross margin is only the starting point. Sales expense, research spending, infrastructure, taxes, stock compensation, and dilution determine how much value ultimately reaches each share. Zscaler has demonstrated strong product economics, but the handoff does not yet establish strong owner earnings per diluted share.

2. Valuation is the central permanent-loss risk

The value and safe analysts make the strongest argument: the current price already capitalizes a substantial portion of Zscaler’s expected maturation.

At approximately $32 billion:

Normalized owner earningsInitial owner-earnings yieldApproximate growth hurdle cited in debate
$1.0 billion3.1%About 10% annually
$800 million2.5%About 13%–14% annually
$600 million1.9%About 17% annually

The $1 billion case could make $196 reasonable if dilution-adjusted cash generation compounds reliably. But that starting figure has not been verified. At $600 million–$800 million, the price requires much stronger execution and leaves limited protection if growth slows or margins take longer to mature.

This is why a claimed 10% discount to an optimistic valuation is not yet a genuine margin of safety. A small discount is appropriate for a proven wonderful business; Zscaler’s product quality may merit that status, but its per-share owner economics do not yet.

The risk is not ordinary stock volatility. It is paying today for:

  1. Sustained growth above 20%
  2. Significant operating-margin expansion
  3. Continued module adoption
  4. Stable competitive positioning
  5. Lower stock-based compensation and dilution

A shortfall in only one or two areas could cause permanent valuation compression even if the company remains strategically important.

3. Stock compensation must be measured once—but measured fully

The risky analyst correctly warns against double-counting stock-based compensation. The analysis should either:

  • Treat SBC as an economic expense in owner earnings, or
  • Capture its cost through dilution and the cash required to offset issuance

It should not impose both adjustments for the same cost.

Nevertheless, SBC cannot be dismissed because it supports hiring and retention. The relevant shareholder measures are:

  • Free cash flow per diluted share
  • Fully diluted share-count growth
  • SBC as a percentage of revenue
  • Repurchase spending used merely to offset issuance
  • Owner earnings per share after a consistent dilution adjustment

The available evidence is insufficient to conclude that normalized owner earnings are already near $1 billion. That uncertainty warrants patience.

4. The moat is meaningful but not impregnable

Zscaler benefits from:

  • Cloud-native architecture
  • Security-critical customer relationships
  • Integration into access and compliance processes
  • Switching costs and organizational disruption associated with replacement
  • Opportunities to cross-sell additional users, workloads, and modules

These advantages support a credible moat. Yet the telemetry advantage should not be treated as an unassailable network effect. Microsoft, Palo Alto Networks, CrowdStrike, Cisco, and others possess broad installed bases, adjacent control points, and established enterprise sales channels.

The principal competitive risk is not necessarily mass customer loss. More subtle damage would be enough:

  • Longer sales cycles
  • Greater pricing concessions
  • Slower module expansion
  • Higher customer-acquisition costs
  • Persistently elevated sales expense
  • Bundling that limits incremental adoption

Zscaler can compound without dominating the whole market, but the expected margin expansion requires evidence that platform consolidation is benefiting Zscaler rather than primarily favoring broader vendors.

5. Momentum is tactically positive, not an investment foundation

Near-term positioning is bullish:

  • Put/call open interest: 0.64
  • Put/call volume: 0.51
  • Calls carry an implied-volatility premium across the referenced expirations

That may support continued upside, but it can also indicate elevated expectations and crowded call demand. The 10-day EMA and 50-day SMA can help assess short- and medium-term momentum, but the anomalous 200-day data must be independently verified.

The lessons from the prior Zscaler and Xero assessments are important: a fundamentally cautious long-term judgment can coexist with a sharp short-term rally. Accordingly, the horizons should be separated:

  • Days to weeks: Bullish positioning can extend momentum, but chasing an extended move is risky.
  • One to four quarters: Operating leverage and dilution-adjusted cash flow matter more than options activity.
  • Multiple years: Returns depend on owner earnings per share and the price paid, not temporary technical strength.

Options demand should influence entry timing and position size—not intrinsic value.


Assessment of the Analysts

Fundamentals Analyst — Too bearish

The AVOID rating relies excessively on negative accounting returns. Those figures do not establish permanent impairment in an asset-light company growing revenue above 25% with a gross margin near 77%. They justify demanding better evidence of conversion, not rejecting the business.

Value and Safe Analysts — Strongest on price discipline

Their best points are:

  • The owner-earnings base is unverified.
  • Valuation changes dramatically between $600 million and $1 billion of normalized cash flow.
  • SBC and dilution are genuine shareholder costs.
  • Good operating results can still produce poor stock returns when expectations are excessive.

The safe analyst becomes too rigid only if “no purchase” is applied to every mandate. Limited optional exposure may be reasonable for a diversified growth portfolio, but it is not yet justified as a Buffett-style core holding.

Growth and Risky Analysts — Strong on opportunity, optimistic on conversion

They correctly identify:

  • Structural cybersecurity demand
  • Potential operating leverage
  • Platform expansion
  • The weakness of relying mechanically on ROE and ROA
  • The opportunity cost of waiting for complete maturity

Their weakness is assuming that high gross margins and strong revenue growth will necessarily produce high per-share owner-earnings growth. At $196, that conversion is part of what investors are already paying for.

Neutral Analyst — Best overall balance

The neutral view appropriately distinguishes position sizing from valuation. A small position controls the consequences of being wrong but does not make the shares inexpensive. Its mandate-sensitive approach is preferable to either full advocacy or categorical avoidance.


Refined Investor Plan

Original plan

Keep Zscaler on the watchlist at $196 until normalized owner earnings, dilution, operating leverage, and valuation are better established.

Adjustment

Retain that plan, but explicitly separate investment and tactical decisions.

For a Buffett-style core portfolio

  • Make no full or normal-sized purchase at $196.
  • Do not use short-dated bullish options.
  • Wait for either stronger per-share economics or a materially better price.
  • Do not treat a drawdown alone as proof of value.

For a diversified, growth-tolerant portfolio

  • An optional 0.5%–1% tracking position is defensible.
  • Treat it as risk-budgeted exposure, not evidence of undervaluation.
  • Add only after operating evidence improves or after a price decline that leaves the business thesis intact.
  • Do not average down solely because the stock becomes cheaper.

Upgrade toward ADVOCATE if

  • Revenue growth remains around 20% or better.
  • GAAP and incremental operating margins improve sustainably.
  • Normalized owner earnings approach $1 billion under a credible SBC treatment.
  • Free cash flow per diluted share grows at a low-to-mid-teens rate.
  • SBC as a percentage of revenue and net dilution decline.
  • Multi-module adoption and large-customer expansion remain healthy.
  • The price offers roughly a 10%–15% discount to a conservatively verified value once wide-moat economics are demonstrated—or a larger discount while uncertainty remains.

Downgrade toward AVOID if

  • Growth falls into the low teens without compensating margin expansion.
  • Gross-margin deterioration appears structural.
  • Free cash flow growth fails to translate into per-share growth.
  • Net dilution remains persistently high.
  • Bundling weakens retention, pricing, sales efficiency, or module adoption.
  • Solvency weakens materially alongside deteriorating operations.
  • The price rises while the implied reverse-DCF assumptions become increasingly heroic.

Final Commentary

Zscaler is strategically too strong to dismiss, but its current valuation is too dependent on an unverified earnings transition to justify a Buffett-style purchase. The likely moat, secular growth, and operating leverage make AVOID unnecessarily harsh. Yet the absence of reliable dilution-adjusted owner earnings makes ADVOCATE premature.

Patience should focus on evidence, not perfect certainty: verify that high gross margins are becoming durable owner earnings per share, and require a price that does not assume nearly flawless execution.

WATCH

Scorecard

Overall 2.75 out of 5, weighted as shown.

DimensionWeightScoreWhat it measures
Business Quality30%2.50 / 5High returns, profitability, and Piotroski health support durability.
Valuation Support30%2.00 / 5Blends current price against available intrinsic value anchors and valuation ratios.
Financial Strength20%4.00 / 5Balance-sheet resilience reflects leverage and liquidity staying within safe ranges.
Growth Durability20%3.00 / 5Recent revenue, earnings, and free cash flow growth indicate how durable expansion looks.

The model

Every input behind the value range, so you can check the work or change an assumption and redo it yourself. Computed deterministically from SEC filings (fiscal 2026), updated Oct 4, 2026; the market price was $196.62. Values are estimates, not predictions.

Free cash flow

Discounts reported free cash flow: operating cash flow minus capital expenditure.

Value per share: $115.88 / $191.38 / $487.40 (conservative / base / optimistic)

Starting Free Cash Flow$852M
Growth: conservative / base / optimistic (2018–2026)15.4% / 30.0% / 59.3%
Projection10 years
Discount rate10.0%
Terminal growth2.5%
Shares outstanding160M
The history the growth rates come from (11 years)
2016−$17M
2017−$14M
2018$4M
2019$33M
2020$36M
2021$154M
2022$253M
2023$365M
2024$635M
2025$808M
2026$852M

Two-stage FCFF (Damodaran)

Projects revenue, operating margin and reinvestment, then discounts free cash flow to the firm at the weighted cost of capital.

Value per share: −$320.85 / −$214.20 / −$209.32 (conservative / base / optimistic)

Starting Damodaran FCFF−$133M
Growth: conservative / base / optimistic (2016–2026)25.0% / 25.0% / 35.0%
Projection10 years
Risk-free rate5.28%
Equity risk premium4.15%
Beta1.00
Cost of equity9.43%
After-tax cost of debt6.78%
Equity weight100%
WACC (discount rate)9.43%
Target operating margin (base)-18.2%
High-growth stage5 years
Terminal growth2.5%
Shares outstanding160M

This briefing is from Sep 18, 2026. A fresh one re-reads the latest filings and prices; running it takes a free account.

Run a fresh briefing →Watch the video briefingGet the iPhone app

The Monday letter

One email a week: what great value investors bought and sold, and what we make of it.

Send me the DeepValues Monday letter, one email a week. I can unsubscribe at any time. Information only, not investment advice. Privacy